Does Thiamine Help Vomiting and Nausea in Pregnancy?

Sponsor
HaEmek Medical Center, Israel (Other)
Overall Status
Terminated
CT.gov ID
NCT00861523
Collaborator
(none)
50
1
2
35
1.4

Study Details

Study Description

Brief Summary

There are different treatments for nausea and vomiting in pregnancy. According to the ACOG recommendations, promethazine is the first line of parenteral treatment after oral treatment had failed. Thiamine is given to prevent wernicke encephalopathy. This research try to find out whether thiamine helps the vomiting and nausea as well, by comparing the response to thiamine and promethazine in women who suffer from nausea and vomiting in pregnancy.

Condition or Disease Intervention/Treatment Phase
  • Drug: thiamine & promethazine
Phase 3

Detailed Description

  • Research groups: pregnant women eho visit the emergency room for nausea and vomiting in pregnancy, pregnancy age 12 weeks or less

  • After basic examinations and hydration, the women will randomized to thiamine or promethazine treatment.

  • If no improvement is shown, the patient will be treated with the other drug

  • The patients will be interviewed on their current visit and every two weeks until 14th week of gestation

  • The interview includes medical history and details about their illness, other treatments, hospitalization etc.

Study Design

Study Type:
Interventional
Actual Enrollment :
50 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Comparison Between the Treatment of Thiamine and Promethazine for Improving Vomiting and Nausea in Pregnancy
Study Start Date :
Feb 1, 2009
Actual Primary Completion Date :
Jan 1, 2012
Actual Study Completion Date :
Jan 1, 2012

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: 1. thiamine

Pregnant women until 12 week of gestation who refer to the ER because of nausea and vomiting and didn't improve after hydration, will receive thiamine IV

Drug: thiamine & promethazine
thiamine 100 mg IV promethazine 25 mg IV

Active Comparator: 2. promethazine

Pregnant women until 12 week of gestation who refer to the ER because of nausea and vomiting and didn't improve after hydration, will receive promethazine IV

Drug: thiamine & promethazine
thiamine 100 mg IV promethazine 25 mg IV

Outcome Measures

Primary Outcome Measures

  1. the improvement in nausea and/or vomiting after treatment [2 months after first visit in ER (until 14 week of pregnancy)]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Pregnant women until 12th week of gestation

  • The women visit the ER because of nausea and vomiting

  • The women didn't received thiamine yet

Exclusion Criteria:
  • Pregnant women over 12th week of gestation

  • Women that received thiamine before

  • women that allergic to the studied drugs

Contacts and Locations

Locations

Site City State Country Postal Code
1 Gynecologic department, Haemek medical center Afula Israel

Sponsors and Collaborators

  • HaEmek Medical Center, Israel

Investigators

  • Principal Investigator: Yfat Kadan, haemek medical center

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
HaEmek Medical Center, Israel
ClinicalTrials.gov Identifier:
NCT00861523
Other Study ID Numbers:
  • 0101-08-EMC
First Posted:
Mar 13, 2009
Last Update Posted:
Jun 23, 2015
Last Verified:
Jun 1, 2015

Study Results

No Results Posted as of Jun 23, 2015